Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Neurologic Manifestations: early-phase trial registry

2 of 8 indexed Neurologic Manifestations trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Neurologic Manifestations: 8 US clinical trials tracked, 2 recruiting.

Neurologic Manifestations is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Vanderbilt University Medical Center, running 3 of these trials.

Enrollment posture brief

Registry condition neurologic-manifestations

OPEN 2 | RECR 25% | LATE 1 | EARLY 2 | RANK #2176 | SPON 3

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Neurologic Manifestation (th…25%
Open-enrollment share among volume-matched conditions near Neurologic Manifestations

Neurologic Manifestations lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Neurologic Manifestations on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Neurologic Manifestations is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Neurologic Manifestations research.

    Vanderbilt University Medical Center accounts for 3 of 8 trials (37.5%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Neurologic Manifestations enrolment sits around 300 participants.

    Median target enrolment is 300 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.

  4. Neurologic Manifestations splits between interventional and observational designs.

    4 interventional and 4 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 31

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1

Named interventions

Most-linked intervention names on Neurologic Manifestations records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

0.9% saline Drug
1 trials
This study does not entail offering any intervention; all data collected will be based on standard of care. Other
1 trials
Video game based training Behavioral
1 trials
Teleneurological Examination Diagnostic test
1 trials
Neurological Examination Diagnostic test
1 trials
Neurological Examination Other
1 trials
Bedside Referral Tool Diagnostic test
1 trials
Patient-Centered Chronic Pain Management Visits Behavioral
1 trials

US sites by state

Facility locations filed on Neurologic Manifestations trials. A trial with sites in several states counts in each.

Tennessee 4 trials
New York 2 trials
North Carolina 2 trials
California 2 trials
Utah 1 trials
Texas 1 trials
South Carolina 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Neurologic Manifestations page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurologic Manifestations condition card totals 8 registered trials; most-linked intervention 0.9% saline; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.